• Order Online

Hat-trick of awards doubles for CellPath

Paul Webber CellPath Joint Managing Director Peter Webber CellPath Chairman CellPath MediWales Awards Winners 2019 Richard Titcombe CellPath Senior Project Manager National Museum Cardiff

Presented at the National Museum Cardiff in front of guests from the industry; the NHS, government and academia who had gathered to celebrate the achievements on the Welsh Life Sciences sector. CellPath was thrilled to be awarded both the Export Achievement and Outstanding Achievement Award, at the MediWales Innovation Awards 2019.

These two awards add to four already proudly won in a busy and successful year for the company. A year that has seen employee numbers increase in-line with turnover and significant capital investments made to ensure its future success.

Paul Webber, CellPath’s Joint Managing Director, commented:

“We’ve had a fantastic year on the awards front which is a testament to the commitment and hard work from all employees here at CellPath. Hopefully, we can continue the trend next year!”


About MediWales

MediWales is an independent not-for-profit company and is the life sciences network and representative body for Wales. Founded in 1992, MediWales provides advice, support and business opportunities for its members promoting collaboration within the life science and health technology community in Wales.

With 180 members, the MediWales network is made-up of medical technology companies, life science organisations and pharmaceutical services. MediWales actively encourages engagement with the research community and its members, including NHS health boards and universities.

The key roles include engaging with government to align support with sector needs, facilitating access to global trade opportunities and improving access to vital clinical expertise and facilitates.


Winners in the Industry category were:

Innovation – Magstim, which manufactures and supplies Transcranial Magnetic Stimulation (TMS) equipment for the treatment of depression. The company has recently launched StimGuide, an innovative 3D TMS navigation system developed for the clinical setting.

Start-up – CanSense, which has developed an accurate, fast and non-invasive diagnostic for early detection of bowel cancer using a simple blood sample. The technology enables GPs to make quicker decisions and speeds up the diagnostic process for the patients at greatest risk.

Export CellPath, a long-established family business specialising in the manufacture and worldwide supply of consumables, equipment and services to aid hospitals in cancer diagnostics. Export sales have increased thanks to the opening of a new International Distribution Centre, and franchising agreements have been arranged across Europe for their storage solutions.

Partnership with the NHS – Creo Medical, a medical device company focused on surgical endoscopy and minimally invasive surgery. Working in partnership with East Kent Hospitals, the company developed its advanced energy platform and endoscopic Speedboat device, which now allows complex cases to be treated on-site rather than referred elsewhere.

Outstanding Achievement CellNass, an innovative archive management service delivered by CellPath. The organisation is celebrating its 17th successive year of growth since service launch, with a 100% customer retention rate and adoption in most NHS hospitals. 

Industry Judges Award – Blackwood Embedded Solutions, which specialises in medical embedded systems, providing both software and electronic design. The company changed its design approach and completed three medical device proofs-of-concept in one year, with just a small team and limited funding.


Winners in the NHS category were:

Innovation within NHS Wales – Cardiff & Vale University Health Board has developed a transitional cross-boundary Supportive Care Pathway for heart failure patients who are towards the end of their lives. It has resulted in increased and earlier referrals to palliative care, with improved quality of life and a significant reduction in readmissions to hospital in the last year of life.

NHS Wales Collaboration with Welsh Industry – Aneurin Bevan University Health Board has worked with SEWAHSP and Orchard Media to develop 10 virtual reality experiences that encourage young people to consider a career in the NHS. They hope to boost understanding of NHS workforce challenges, increase employment within local communities and more.

Efficiency through Technology Programme – High Impact Award – The All Wales Medical Genomics Service has developed a new test called non-invasive prenatal test (NIPT). The test can now be offered to pregnant women in Wales as an alternative to an invasive test which has an associated risk of miscarriage.

Health and Social Care Research Partnership with Industry – In Velindre University NHS Trust’s FAKTION trial, patients with the most common type of incurable breast cancer received therapy with a novel AKT inhibitor, supplied by Astra Zeneca. The results were overwhelmingly positive, showing significant improvements in cancer shrinkage and control.

NHS Judges Award – The Staying Steady Schools project is an intergenerational falls awareness and healthy ageing scheme, bringing together primary school children and older adults. Sessions are led by healthcare students who are trained by staff from Cardiff & Vale University Health Board and the Local Public Health Team.

Special Mention – Patients Know Best received a special mention at the Awards in recognition of their work with health boards across Wales, empowering patients with the tools and information to self-manage their care. In Swansea Bay University Health Board, Patients Know Best is now active across 15 services.

Back to news